Home >
Medicine Info >
Tavin-EM Tablet
Loading interface...

Tavin-EM Tablet

Manufactured byEMCURE PHARMACEUTICALS LTD
ContainsTenofovir (300 mg) + Emtricitabine (200 mg)
Description
Tavin-EM Tablet is a combination of Tenofovir and Emtricitabine. It is an antiviral medicine used for the treatment of human immunodeficiency virus (HIV) infection (a condition that occurs when the virus attacks the immune system and interferes with your body's ability to fight infections or diseases). Tavin-EM Tablet will not cure HIV infection, but it may delay the progression of a chronic, potentially life-threatening condition known as acquired immunodeficiency syndrome (AIDS) and other HIV-related conditions. This medicine works by preventing the virus from multiplying. Tavin-EM Tablet shows common side effects such as difficulty in sleeping, rash, itching, stomach pain, diarrhoea, weight loss or depressed mood. These side effects usually subside with time. However, if they persist or worsen, consult your doctor for further assistance. Avoid driving vehicles or operating heavy machines while taking this medication as it can cause dizziness and weakness. Tavin-EM Tablet can be taken with or without food. Do not break, chew or crush the tablet. Swallow it whole with a glass of water. Do not discontinue the medication without consulting your doctor as it may cause a risk of re-infection which can be difficult to treat in the future. Complete the treatment even if you start feeling better. Follow the instructions given by your doctor about the dose and duration of the treatment. Tavin-EM Tablet is not recommended for use in children less than 12 years of age. Inform your doctor if you have heart, liver, or kidney problems or any other health conditions. Also, inform your doctor about all your ongoing medications to avoid undesired effects. Tavin-EM Tablet is unsafe for use during pregnancy. Also, consult your doctor if you planning a pregnancy or are breastfeeding.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Tavin-EM Tablet

  • Chest pain
  • Fever or chills
  • Diarrhoea
  • Dizziness
  • Headache
  • Abdominal pain
  • Nausea
  • Joint pain
  • Weight loss
  • Rash
  • Itching
  • Passing gas
  • Lactic Acidosis

Uses of Tavin-EM Tablet

What is it prescribed for?

  • HIV infection
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for Tavin-EM Tablet to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time for which Tavin-EM Tablet remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Tavin-EM Tablet.
  • Can this medicine be taken during pregnancy?
    Tavin-EM Tablet is unsafe for use during pregnancy as it can harm your developing foetus. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Tavin-EM Tablet is not recommended for use while breastfeeding. Hence, consult your doctor if you are breastfeeding.

Allergy

Avoid taking Tavin-EM Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Tavin-EM Tablet is unsafe for use during pregnancy as it can harm your developing foetus. Hence, consult your doctor if you are pregnant.

Breast-feeding

Tavin-EM Tablet is not recommended for use while breastfeeding. Hence, consult your doctor if you are breastfeeding.
General warnings

Driving vehicles or operating machines

Tavin-EM Tablet may cause dizziness or drowsiness. It is advised that you do not perform any activities such as driving vehicles or operating machines if you experience any of these symptoms during treatment with this medicine.

Liver problems

Tavin-EM Tablet should be taken with caution if you have a liver condition such as hepatitis B, C and cirrhosis. Follow all the instructions given by your doctor.

Lactic acidosis

Lactic acidosis is a build-up of lactic acid in the bloodstream. Tavin-EM Tablet should be used with caution due to the increased risk of lactic acidosis. Report any unusual symptoms like muscle cramps, unusual weakness or tiredness, feeling dizzy or lightheaded, fast or abnormal heartbeat, etc., to your doctor immediately.

Decreased bone mineral density

Tavin-EM Tablet should be used with caution as it may cause a decrease in bone mineral density (amount of bone mineral in your bones).

Fat redistribution

Tavin-EM Tablet should be used with caution as it may cause redistribution or accumulation of body fat. It may result in central obesity, buffalo hump (excess fat behind the neck), peripheral wasting (difficulty in moving an arm or leg or making any movement), facial wasting (fat loss in the cheeks and temples), breast enlargement, and cushingoid appearance (extra fat build up on the sides of the face and weight gain). Consult your doctor if you have any concerns.

Immune Reconstitution Syndrome

Changes in your immune system can occur when you start taking Tavin-EM Tablet. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. It may cause an exaggerated response making the symptoms of infection worse. Inform your doctor if you develop any new symptoms after starting treatment with Tavin-EM Tablet.

Kidney disease

Tavin-EM Tablet should be taken with caution if you have a kidney condition, as it can worsen your condition. Follow all the instructions given by your doctor.

65 years of age

Tavin-EM Tablet should be taken with caution if you are 65 years of age or above.

Missed Dose

Do not miss the dose of Tavin-EM Tablet. In case you miss a dose, take it as soon as you remember. However, if it is time for the next dose, then skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Do not take more than the prescribed dose of Tavin-EM Tablet. Seek emergency medical treatment in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Cisplatin

Gentamicin

Atazanavir

Darunavir

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Tavin-EM Tablet with or without food. Do not break, chew, or crush the tablet. Swallow it as a whole with a glass of water. It should not be taken for more than recommended dose. Take the medicine as directed by your doctor. Take it at the same time every day for the ease of remembering. Do not stop the medicine without consulting your doctor as it can increase the chance of reinfection which may be difficult to treat in the future. Your doctor may suggest tests to monitor your kidney and liver function.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Tavin-EM Tablet is a combination of Tenofovir and Emtricitabine. It works by stopping the human immunodeficiency virus (HIV) from multiplying. This helps in reducing the chances of the development of acquired immunodeficiency syndrome (AIDS) caused by HIV and other HIV-related illnesses.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antiviral combinations

Schedule

Schedule H

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 29 July 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021752s035lbl.pdf

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 29 July 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022577lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 Jan 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.